UiPath Partners with HCLTech to Accelerate Agentic Automation for Global Enterprises
NEW YORK & NOIDA, India--(BUSINESS WIRE)--UiPath (NYSE: PATH), a global leader in agentic automation, today announced a strategic partnership with HCLTech, a leading global technology company, to accelerate agentic automation for UiPath customers globally across industries. The partnership will drive large-scale transformation for UiPath customers, enabling more intelligent and self-sufficient operations that require minimal human intervention.
HCLTech will leverage its AI expertise to deploy the UiPath Platform™, enabling autonomous operations in finance, supply chain, procurement, customer service, marketing and human resources. HCLTech will support this partnership with pre-configured AI agents and controls to ensure seamless deployment and scalability. The partnership aims to enhance business agility, optimize workforce efficiency and deliver faster returns on business process automation investments for global enterprises.
HCLTech will also establish an AI Lab with UiPath in India to develop Industry Focused Repeatable Solutions (IFRS) and MVPs for the full automation lifecycle, from strategy to implementation and continuous optimization. HCLTech will leverage its global delivery model to support UiPath customers in North America, Europe and Asia-Pacific.
"As we shift towards a new era with agentic AI, agentic automation will be critical to provide businesses with the speed and agility to transform operations and unlock new business potential. Partnering with HCLTech allows UiPath to extend the power of its AI-powered automation to enterprises globally, accelerating intelligent transformation at scale. With HCLTech's deep expertise in AI, automation and industry solutions, UiPath customers will benefit from best-in-class implementation and business impact," said Ashim Gupta, Chief Operating Officer and Chief Financial Officer, UiPath.
"By co-creating next-gen AI-powered solutions with UiPath, HCLTech is setting new benchmarks for agentic autonomous operations that unlock unprecedented efficiency, agility and innovation for enterprises. Our proven expertise in hyperautomation, AI and cloud-first architectures helps us provide industry-specific and advanced automation solutions at scale," said Raghu Kidambi, Corporate Vice President and Global Head, Digital Process Operations, HCLTech.
About HCLTech
HCLTech is a global technology company, home to more than 223,000 people across 60 countries, delivering industry-leading capabilities centered around digital, engineering, cloud and AI, powered by a broad portfolio of technology services and products. We work with clients across all major verticals, providing industry solutions for Financial Services, Manufacturing, Life Sciences and Healthcare, Technology and Services, Telecom and Media, Retail and CPG and Public Services. Consolidated revenues as of 12 months ending March 2025 totaled $13.8 billion. To learn how we can supercharge progress for you, visit hcltech.com.
About UiPath
UiPath (NYSE: PATH) is a global leader in agentic automation, empowering enterprises to harness the full potential of AI agents to autonomously execute and optimize complex business processes. The UiPath Platform™ uniquely combines controlled agency, developer flexibility, and seamless integration to help organizations scale agentic automation safely and confidently. Committed to security, governance, and interoperability, UiPath supports enterprises as they transition into a future where automation delivers on the full potential of AI to transform industries. For more information, visit www.uipath.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
32 minutes ago
- Yahoo
AM Best Revises Outlooks to Negative for UnitedHealth Group Incorporated and Its Subsidiaries
OLDWICK, N.J., June 04, 2025--(BUSINESS WIRE)--AM Best has revised the outlooks to negative from stable and affirmed the Long-Term Issuer Credit Ratings (Long-Term ICR) of "a" (Excellent) and the Long-Term Issue Credit Ratings (Long-Term IRs) of UnitedHealth Group Incorporated (UnitedHealth Group) (Minnetonka, MN) [NYSE: UNH]. AM Best also has affirmed the Short-Term IR of UnitedHealth Group. Concurrently, AM Best has revised the outlooks to negative from stable and affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term ICRs of "aa-" (Superior) of the health and dental insurance subsidiaries of UnitedHealth Group, collectively referred to as UnitedHealthcare. (See link below for a detailed listing of the companies and ratings.) The ratings reflect UnitedHealthcare's balance sheet strength, which AM Best assesses as strong, as well as its very strong operating performance, very favorable business profile and appropriate enterprise risk management (ERM). The revision of the outlooks to negative from stable reflects the expected deterioration in operating performance in 2025 driven by the Medicare Advantage segment. In UnitedHealth Group's first-quarter earnings, the company noted an acceleration in trends in the Medicare Advantage segment that occurred late in the quarter. In May 2025, the company announced that trends continued to accelerate and broadened to more types of benefit offerings. Additionally, UnitedHealth Group noted that the medical costs of many Medicare Advantage beneficiaries new to UnitedHealthcare remained higher than expected. Due to the design of the Medicare Advantage program, UnitedHealthcare is unable to implement corrective pricing actions until 2026, and the issues within the Medicare Advantage segment are expected to persist for the remainder of 2025. AM Best will continue to monitor UnitedHealth Group's operating performance and may take rating action should operating performances no longer be in line with the very strong assessment. UnitedHealthcare's risk-adjusted capitalization, as measured by Best's Capital Adequacy Ratio, is at the very strong level. Capital and surplus growth is supported by retained net earnings in excess of dividends to the parent. UnitedHealthcare actively manages subsidiary risk-adjusted capital on a near- to long-term basis to ensure capital levels are supportive of premium growth. Investment risk is on the low side with a conservative asset allocation and no material exposure to equities, real estate or schedule BA assets. UnitedHealthcare holds a substantial market share in all lines of business and on a national basis. Premiums and earnings are well-diversified by business segment and geography. Furthermore, its large membership base provides economies of scale. UnitedHealth Group's ERM program is developed, and the group's risk management capabilities are aligned with its risk profile. The ERM program is dynamic and utilized in daily operations and strategic business planning. However, AM Best recognizes the missteps that have occurred within the organization, including the Change Healthcare cyber-attack as well as the issues addressed in the recent earnings announcements. AM Best evaluates UnitedHealth Group's ERM as appropriate. UnitedHealth Group has strong financial flexibility with material non-regulated operating cash flows from its Optum operations. Equity has shown consistent growth over the past five years, driven entirely by retained earnings despite large share repurchases and growing dividend programs. Strong liquidity is driven by favorable operating cash flows, parent company cash, a commercial paper program and a $21 billion revolving credit facility. Financial leverage at year-end 2024 was elevated at 43.7%, as measured by AM Best, and is above the company's long-term target of 40%. Additionally, earnings before interest and tax coverage remained good but declined in 2024 to about eight times. Furthermore, UnitedHealth Group had a large amount of goodwill and intangibles on the balance sheet totaling approximately 132% of equity. There has been no history of any material impairments and acquired assets continue to contribute favorably to revenues and earnings. A complete listing of UnitedHealth Group's FSRs and Long-Term ICRs, as well as Short- and Long-Term IRs, is available. This press release relates to Credit Ratings that have been published on AM Best's website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best's Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings. For information on the proper use of Best's Credit Ratings, Best's Performance Assessments, Best's Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best's Ratings & Assessments. AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit Copyright © 2025 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED. View source version on Contacts Bridget Maehr Director +1 908 882 2080 Sally Rosen Senior Director +1 908 882 2284 Christopher Sharkey Associate Director, Public Relations +1 908 882 2310 Al Slavin Senior Public Relations Specialist +1 908 882 2318 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
37 minutes ago
- Business Wire
AM Best Revises Outlooks to Negative for UnitedHealth Group Incorporated and Its Subsidiaries
BUSINESS WIRE)-- AM Best has revised the outlooks to negative from stable and affirmed the Long-Term Issuer Credit Ratings (Long-Term ICR) of 'a' (Excellent) and the Long-Term Issue Credit Ratings (Long-Term IRs) of UnitedHealth Group Incorporated (UnitedHealth Group) (Minnetonka, MN) [NYSE: UNH]. AM Best also has affirmed the Short-Term IR of UnitedHealth Group. Concurrently, AM Best has revised the outlooks to negative from stable and affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term ICRs of 'aa-' (Superior) of the health and dental insurance subsidiaries of UnitedHealth Group, collectively referred to as UnitedHealthcare. (See link below for a detailed listing of the companies and ratings.) The ratings reflect UnitedHealthcare's balance sheet strength, which AM Best assesses as strong, as well as its very strong operating performance, very favorable business profile and appropriate enterprise risk management (ERM). The revision of the outlooks to negative from stable reflects the expected deterioration in operating performance in 2025 driven by the Medicare Advantage segment. In UnitedHealth Group's first-quarter earnings, the company noted an acceleration in trends in the Medicare Advantage segment that occurred late in the quarter. In May 2025, the company announced that trends continued to accelerate and broadened to more types of benefit offerings. Additionally, UnitedHealth Group noted that the medical costs of many Medicare Advantage beneficiaries new to UnitedHealthcare remained higher than expected. Due to the design of the Medicare Advantage program, UnitedHealthcare is unable to implement corrective pricing actions until 2026, and the issues within the Medicare Advantage segment are expected to persist for the remainder of 2025. AM Best will continue to monitor UnitedHealth Group's operating performance and may take rating action should operating performances no longer be in line with the very strong assessment. UnitedHealthcare's risk-adjusted capitalization, as measured by Best's Capital Adequacy Ratio, is at the very strong level. Capital and surplus growth is supported by retained net earnings in excess of dividends to the parent. UnitedHealthcare actively manages subsidiary risk-adjusted capital on a near- to long-term basis to ensure capital levels are supportive of premium growth. Investment risk is on the low side with a conservative asset allocation and no material exposure to equities, real estate or schedule BA assets. UnitedHealthcare holds a substantial market share in all lines of business and on a national basis. Premiums and earnings are well-diversified by business segment and geography. Furthermore, its large membership base provides economies of scale. UnitedHealth Group's ERM program is developed, and the group's risk management capabilities are aligned with its risk profile. The ERM program is dynamic and utilized in daily operations and strategic business planning. However, AM Best recognizes the missteps that have occurred within the organization, including the Change Healthcare cyber-attack as well as the issues addressed in the recent earnings announcements. AM Best evaluates UnitedHealth Group's ERM as appropriate. UnitedHealth Group has strong financial flexibility with material non-regulated operating cash flows from its Optum operations. Equity has shown consistent growth over the past five years, driven entirely by retained earnings despite large share repurchases and growing dividend programs. Strong liquidity is driven by favorable operating cash flows, parent company cash, a commercial paper program and a $21 billion revolving credit facility. Financial leverage at year-end 2024 was elevated at 43.7%, as measured by AM Best, and is above the company's long-term target of 40%. Additionally, earnings before interest and tax coverage remained good but declined in 2024 to about eight times. Furthermore, UnitedHealth Group had a large amount of goodwill and intangibles on the balance sheet totaling approximately 132% of equity. There has been no history of any material impairments and acquired assets continue to contribute favorably to revenues and earnings. A complete listing of UnitedHealth Group's FSRs and Long-Term ICRs, as well as Short- and Long-Term IRs, is available.
Yahoo
39 minutes ago
- Yahoo
Pro-XRP lawyer John Deaton warns against using home equity to buy Bitcoin
Pro-XRP lawyer John Deaton warns against using home equity to buy Bitcoin originally appeared on TheStreet. Pro-XRP lawyer John Deaton has sounded the alarm over the latest investment trends emerging in the Bitcoin community. There are multiple ways to trade Bitcoin in the U.S. One can directly trade in BTC over centralized or decentralized crypto exchanges, invest in stocks of Bitcoin-focused companies such as Strategy (Nasdaq: MSTR), or invest in exchange-traded funds (ETFs) tied to Bitcoin. There are even more innovative ways of Bitcoin investing that are gaining the attention of the trading community. One such way is using home equity to invest in Bitcoin. Recently, a technology company Horizon launched a program that lets a homeowner access a portion of their home's equity — without monthly payments — and invest some of that equity in Bitcoin. Deaton cautioned against such trends in Bitcoin investing even as he reminded everyone that he is himself a Bitcoin bull. He reminded his followers on X that he disclosed holding 80% of his net worth in Bitcoin to the Federal Election Committee (August 2024 Senatorial financial disclosures). He added that he even took on Democrat Elizabeth Warren in Massachusetts during the 2024 election, who he says sought a ban against self-custody of Bitcoin in the country. Nonetheless, Deaton said Bitcoin investing trends such as mortgaging homes or acquiring preferred stocks offered by Strategy for the purpose could lead to "bad outcomes" for such investors due to risks involved. Bitcoin has had a terrific year so far and has grown nearly 50% over the last 12 months. As per Kraken, it was trading at $105,370.29 at press time. Pro-XRP lawyer John Deaton warns against using home equity to buy Bitcoin first appeared on TheStreet on Jun 4, 2025 This story was originally reported by TheStreet on Jun 4, 2025, where it first appeared. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
